Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AdaptHealth Corp.AHCO · Entity 5183 | Director | May 11, 2021 | May 13, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AdaptHealth Corp.
Report date May 11, 2021 · Filed May 13, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnote | 1,000 |
Reported balance
After 2021-05-11 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2021-05-11 · Purchase · Acquired 1,000 · Balance 1,000 F1: Securities held in a trust, of which the spouse of the reporting person is a trustee and beneficiary. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
| Class A Common StockSEC Table I · non-derivative | Direct | 11,886 |
Reported balance
Holding disclosure · report date 2021-05-11 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 11,886 |
Filing footnotes · ownership attribution and instrument terms
F1: Securities held in a trust, of which the spouse of the reporting person is a trustee and beneficiary. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 11, 2021 Filed May 13, 2021 16:58 UTC | AdaptHealth Corp. AHCO · Entity 5183 | PurchaseClass A Common Stock | 1,000 | $24.64 | $24,640.00 |
DisclosureSEC source: 0001104659-21-066002 · tm2116205-1_4seq1.xml · nonDerivative · entry 2 QUASHA ALAN G · CIK 0000921100 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,000 F1 · ownership.nature: Securities held in a trust, of which the spouse of the reporting person is a trustee and beneficiary. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 09, 2020 Filed Sep 11, 2020 21:04 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantClass A Common Stock | 5,636 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-104533 · a4.xml · nonDerivative · entry 1 QUASHA ALAN G · CIK 0000921100 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,886 Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 21:31 UTC | AdaptHealth Corp. AHCO · Entity 5183 | GrantClass A Common Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-073993 · a4.xml · nonDerivative · entry 1 QUASHA ALAN G · CIK 0000921100 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.